Neutralizing Monoclonal Antibodies for Coronavirus Disease 2019 (COVID-19) in Pregnancy: A Case Series

To describe outcomes associated with monoclonal antibody use in pregnant persons with mild-to-moderate coronavirus disease 2019 (COVID-19). METHODS: We present a retrospective case series of pregnant patients who received anti–severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) monoclonal a...

Descripción completa

Detalles Bibliográficos
Autores principales: Richley, Michael, Rao, Rashmi R., Afshar, Yalda, Mei, Jenny, Mok, Thalia, Vijayan, Tara, Weinstein, Stacey, Pham, Christine U., Madamba, Jason, Shin, Christina S., Suda, Deborah, Han, Christina S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Contents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843364/
https://www.ncbi.nlm.nih.gov/pubmed/35115451
http://dx.doi.org/10.1097/AOG.0000000000004689

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843364/
https://www.ncbi.nlm.nih.gov/pubmed/35115451
http://dx.doi.org/10.1097/AOG.0000000000004689

Ejemplares similares